We use cookies to understand how you use our site and to improve your experience. This includes personalizing content and advertising. To learn more, click here. By continuing to use our site, you accept our use of cookies. Cookie Policy.

Features Partner Sites Information LinkXpress
Sign In
Advertise with Us
PURITAN MEDICAL

EKF Diagnostics

Manufactures analysers for the measurement of glucose, lactate, hemoglobin, hematocrit and HbA1c for GP surgeries, ph... read more Featured Products: More products

Download Mobile App





EKF Diagnostics Showcases Latest Data Management Solutions

By LabMedica International staff writers
Posted on 05 Feb 2018
Print article
The DiaSpect Tm hemoglobin analyzer (Photo courtesy of EKF Diagnostics).
The DiaSpect Tm hemoglobin analyzer (Photo courtesy of EKF Diagnostics).
EKF Diagnostics (Cardiff, UK) showcased its latest data management solutions for the DiaSpect Tm hemoglobin analyzer and Quo-Test HbA1c analyzer at MEDLAB Middle East 2018 held in Dubai, UAE from February 5-8, 2018.
 
EKF was among the exhibitors at the event who showcased the latest innovations, products and cutting-edge technologies available in the IVD, medical laboratory and healthcare market. Among the company’s range of Point of Care (POC) hemoglobin analyzers displayed at MEDLAB Middle East were Hemo Control, DiaSpect Tm and HemataStat II. The Hemo Control POC hemoglobin analyzer is designed to provide quantitative, lab quality hemoglobin results from 25 seconds and is used in blood banks, hospitals and doctors’ offices for routine screening for anemia. The company’s DiaSpect Tm is the world’s fastest hemoglobin analyzer. DiaSpect Tm and delivers laboratory quality results in just about one second of the microcuvette being placed into the analyzer. The HemataStat II is a microhematocrit centrifuge that provides a quantitative hematocrit reading for up to six blood samples from one 60 second spin.
 
Among EKF’s range of POC diabetes analyzers on display at this year’s MEDLAB Middle East was Quo-Lab, Quo-Test, Biosen and STAT-Site M BHB. The Quo-Lab HbA1c is a semi-automated desktop analyzer for measuring glycated hemoglobin (HbA1c), while the Quo-Test HbA1c system is a fully automated hemoglobin A1c analyzer. The Biosen series of glucose analyzers include three different models and can be manufactured as single channel glucose systems or as dual channel systems that can measure lactate at the same time. The STAT-Site M BHB analyzer is used for the quantitative determination of B-Hydroxybutyrate (Beta-Hydroxybutyrate or BHB) in serum or plasma. EKF also displayed products for maternal & women’s health, including the Creamatocrit Plus POC analyzer and pregnancy tests.
 
At MEDLAB Middle East 2018, EKF also showcased products from its Central Laboratory division, which included the Stanbio Chemistry range of reagents, controls, calibrators and standards and its own range of benchtop lab analyzers.        
 
Platinum Member
COVID-19 Rapid Test
OSOM COVID-19 Antigen Rapid Test
Magnetic Bead Separation Modules
MAG and HEATMAG
Complement 3 (C3) Test
GPP-100 C3 Kit
Gold Member
Real-time PCR System
GentierX3 Series

Print article

Channels

Clinical Chemistry

view channel
Image: The 3D printed miniature ionizer is a key component of a mass spectrometer (Photo courtesy of MIT)

3D Printed Point-Of-Care Mass Spectrometer Outperforms State-Of-The-Art Models

Mass spectrometry is a precise technique for identifying the chemical components of a sample and has significant potential for monitoring chronic illness health states, such as measuring hormone levels... Read more

Molecular Diagnostics

view channel
Image: Liquid biopsy could detect and monitor aggressive small cell lung cancer (Photo courtesy of Shutterstock)

Blood-Based Test Detects and Monitors Aggressive Small Cell Lung Cancer

Small cell lung cancer (SCLC) is a highly aggressive type of cancer known for its ability to metastasize. The behavior of tumors is largely governed by which genes are turned on, or transcribed, irrespective... Read more

Hematology

view channel
Image: The CAPILLARYS 3 DBS devices have received U.S. FDA 510(k) clearance (Photo courtesy of Sebia)

Next Generation Instrument Screens for Hemoglobin Disorders in Newborns

Hemoglobinopathies, the most widespread inherited conditions globally, affect about 7% of the population as carriers, with 2.7% of newborns being born with these conditions. The spectrum of clinical manifestations... Read more

Immunology

view channel
Image: The groundbreaking treatment approach has shown promise in hard-to-treat cancers (Photo courtesy of 123RF)

Genetic Testing Combined With Personalized Drug Screening On Tumor Samples to Revolutionize Cancer Treatment

Cancer treatment typically adheres to a standard of care—established, statistically validated regimens that are effective for the majority of patients. However, the disease’s inherent variability means... Read more

Microbiology

view channel
Image: Microscope image showing human colorectal cancer tumor with Fusobacterium nucleatum stained in a red-purple color (Photo courtesy of Fred Hutch Cancer Center)

Mouth Bacteria Test Could Predict Colon Cancer Progression

Colon cancer, a relatively common but challenging disease to diagnose, requires confirmation through a colonoscopy or surgery. Recently, there has been a worrying increase in colon cancer rates among younger... Read more
Copyright © 2000-2024 Globetech Media. All rights reserved.